Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1

Status

Recruiting 6Completed 6Unknown 3Active not recruiting 2Withdrawn 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Thoracic 1Genitourinary 1

Conditions

Tuberous Sclerosis 1Neoplasms 1Epilepsy 1Carcinoma, Transitional Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 517Radiotherapy 378Cyclophosphamide 368Carboplatin 359Capecitabine 342Paclitaxel 337Oxaliplatin 336Gemcitabine 322Docetaxel 317Fluorouracil 290Drug Therapy 276Bevacizumab 248apatinib 247camrelizumab 219Etoposide 201Irinotecan 182Doxorubicin 181Leucovorin 163Dexamethasone 161pembrolizumab 153Neoadjuvant Therapy 146sintilimab 145anlotinib 140Blood Specimen Collection 140Pemetrexed 138Cytarabine 138toripalimab 133Surgical Procedures, Operative 131Radiosurgery 131S 1 (combination) 125

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Fluid Therapy × Clear all
NCT04987463 2024-02-08

ViRap

Children's Memorial Health Institute, Poland

Phase 2/3 Unknown
60 enrolled

Epilepsy, Neoplasms, Tuberous Sclerosis

NCT03062059 2022-04-14

The Effectiveness and Safety of Intravesical Gemcitabine Instillation to Prevent Intravesical Recurrence

National Cancer Center, Korea

Phase 2 Unknown
134 enrolled
Genitourinary

Carcinoma, Transitional Cell

NCT02894853 2017-09-14

LEMA

The Netherlands Cancer Institute

Unknown
1,297 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡